Minimally Invasive Benign Hysterectomy
Benign Hysterectomy; a Randomized Controlled Trial Comparing Robotic Hysterectomy With Vaginal Hysterectomy and Traditional Laparoscopic Hysterectomy
A randomised controlled trial comparing hysterectomy by minimally invasive surgical methods; robotic hysterectomy versus vaginal hysterectomy or traditional laparoscopic hysterectomy; outcome and cost analyses.
Laparoscopic surgery is advantageous compared to open surgery in terms of patient morbidity, shorter hospitalization and a more rapid return to daily activities. Robot-assisted laparoscopic surgery have facilitated a higher proportion of minimally invasive surgery first and foremost within gynecologic oncology.It is not clear whether or not this is true for less advanced surgery where a vaginal approach or a traditional laparoscopic approach is possible. Robot-assisted surgery is associated with additional cost due to investment and more expensive surgical equipment. The study is performed to investigate whether or not performing hysterectomy for benign conditions with robotic surgery will be advantageous in terms of shorter operating time, less complications, less conversions to open surgery, and shorter hospital stay in comparison to other minimally invasive procedures such as vaginal hysterectomy and traditional laparoscopic hysterectomy.
Cost of surgery
Study Arms / Comparison Groups
Description: Minimally invasive hysterectomy by robotic surgery
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Primary Completion Date
Inclusion Criteria: - indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer - size of uterus and vagina allows for retrieval by the vaginal route - maximum uterine size equivalent to 16 weeks of pregnancy - informed consent Exclusion Criteria: - malignant disease - known extensive intra-abdominal adhesions - anaesthesiological contraindications to laparoscopic surgery - women with pacemaker or other implants where electrosurgery is to be avoided - immunoincompetent women - simultaneous need for prolapse surgery - women with known defects of the hemostasis - allergies towards metronidazole and doxycycline - inability to understand patient information
25 Years - N/A
Accepts Healthy Volunteers
Jan Persson, MD, PhD, +4646171000, [email protected]
Jan Persson, MD, PhD, Study Director, Department of Obstetrics and Gynecology, Skane University Hospital, Lund